Kämpfer AAM, Busch B, Büttner V, Bredeck G, Stahlmecke B, Hellack B, Masson I, Albrecht C, Schins RP: Model complexity as determining factor for in vitro nanosafety studies – Effects of silver and titanium dioxide nanomaterials in intestinal models. Small 17(15): e2004223, 2021. doi: 10.1002/smll.202004223
Monday, 18 January 2021
by Jana Freytag
Data Protection
Thursday, 14 January 2021
by IUF
Krutmann J, Berneburg M: Photodermatologie. Hautarzt 72(1): 1, 2021. doi: 10.1007/s00105-020-04746-5
Tuesday, 12 January 2021
by Jana Freytag
Neuhaus W*: Consensus statement from the European Network of 3R centres (EU3Rnet). ALTEX 38(1): 138-139, 2021. doi: 10.14573/altex.2010061 *Neuhaus has submitted the Consensus Statement on behalf of all participating centres, institutes and societies of EU3Rnet
Tuesday, 12 January 2021
by Jana Freytag
Vargas-Toscano A, Nickel A-C, Li G, Kamp MA, Muhammad S, Leprivier G, Fritsche E, Barker RA, Sabel M, Steiger HJ, Zhang W, Hänggi D, Kahlert UD: Rapalink-1 targets glioblastoma stem cells and acts synergistically with tumor treating fields to reduce resistance against temozolomide. Cancers 12(12): 3859, 2020. doi: 10.3390/cancers12123859
Monday, 21 December 2020
by Jana Freytag
Fischer I, Nickel A-C, Qin N, Taban K, Pauck D, Steiger H-J, Kamp M, Muhammad S, Hänggi D, Fritsche E, Remke M, Kahlert UD: Different calculation strategies are congruent in determining chemotherapy resistance of brain tumors in vitro. Cells 9(12): 2689, 2020. doi: 10.3390/cells9122689
Tuesday, 15 December 2020
by Jana Freytag